View in EDS

A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.

Saved in:
Bibliographic Details
Title: A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.
Authors: Aubrey BJ; Massachusetts General Hospital, Boston, MA 02114, United States; Dana-Farber Cancer Institute, Boston, MA 02115, United States., Blonquist T; Dana-Farber Cancer Institute, Boston, MA 02115, United States., McMasters M; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States., Hobbs G; Massachusetts General Hospital, Boston, MA 02114, United States., McAfee S; Massachusetts General Hospital, Boston, MA 02114, United States., Rosenblatt J; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States., Amrein P; Massachusetts General Hospital, Boston, MA 02114, United States., Connolly C; Massachusetts General Hospital, Boston, MA 02114, United States., Ramos A; Massachusetts General Hospital, Boston, MA 02114, United States., Logan E; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States., Dey B; Massachusetts General Hospital, Boston, MA 02114, United States., Spitzer T; Massachusetts General Hospital, Boston, MA 02114, United States., Avigan D; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States., Chen YB; Massachusetts General Hospital, Boston, MA 02114, United States., Ballen K; University of Virginia, Charlottesville, VA 22904, United States., El-Jawahri A; Massachusetts General Hospital, Boston, MA 02114, United States., Fathi AT; Massachusetts General Hospital, Boston, MA 02114, United States., Brunner AM; Massachusetts General Hospital, Boston, MA 02114, United States. Electronic address: abrunner@mgh.harvard.edu.
Source: Leukemia research [Leuk Res] 2025 Jun; Vol. 153, pp. 107693. Date of Electronic Publication: 2025 Apr 12.
Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-5835
DOI:10.1016/j.leukres.2025.107693